Proto Labs Inc: Form 10-K for the period ended Dec 31, 2021
Filed with the SEC on Feb 18, 2022 and accepted by EDGAR at Feb 18, 2022, 11:31 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2021-01-01 to 2021-12-31 | $488.1m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 12 months2021-01-01 to 2021-12-31 | $265.4m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2021-01-01 to 2021-12-31 | $222.7m | us-gaap:GrossProfit |
| Research and development | 12 months2021-01-01 to 2021-12-31 | $44.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2021-01-01 to 2021-12-31 | $40.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2021-01-01 to 2021-12-31 | $6.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2021-01-01 to 2021-12-31 | $33.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2021-01-01 to 2021-12-31 | $1.21 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2021-01-01 to 2021-12-31 | $1.21 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2021-01-01 to 2021-12-31 | 27,653,099 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2021-01-01 to 2021-12-31 | $55.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2021-01-01 to 2021-12-31 | $34.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2021-01-01 to 2021-12-31 | $23.3m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2021-12-31 | $65.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-12-31 | $183.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2021-12-31 | $928.6m | us-gaap:Assets |
| Current liabilities | At period end2021-12-31 | $54.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-12-31 | $100.1m | us-gaap:Liabilities |
| Shareholders' equity | At period end2021-12-31 | $828.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-22-003779. Last ingested by Listed: Oct 29, 2026, 14:32 ET. Listed shows no prices and gives no investment advice.